Authors: Sanduleanu, S Jonkers, D de Briune, A Hameeteman, W Stockbrugger, RW

Citation: S. Sanduleanu et al., Changes in gastric mucosa and luminal environment during acid-suppressive therapy: A review in depth, DIG LIVER D, 33(8), 2001, pp. 707-719

Authors: Sanduleanu, S Jonkers, D De Bruine, A Hameeteman, W Stockbrugger, RW

Citation: S. Sanduleanu et al., Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis, ALIM PHARM, 15(8), 2001, pp. 1163-1175

Authors: Sanduleanu, S Jonkers, D De Bruine, A Hameeteman, W Stockbrugger, RW

Citation: S. Sanduleanu et al., Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa, ALIM PHARM, 15(3), 2001, pp. 379-388

Authors: Sanduleanu, S De Bruine, A Stridsberg, M Jonkers, D Biemond, I Hameeteman, W Lundqvist, G Stockbrugger, RW

Citation: S. Sanduleanu et al., Serum chromogranin A as a screening test for gastric enterochromaffin-likecell hyperplasia during acid-suppressive therapy, EUR J CL IN, 31(9), 2001, pp. 802-811

Authors: Jonkers, D Houben, P Hameeteman, W Stobberingh, E de Bruine, A Arends, JW Biemond, I Lundqvist, G Stockbrugger, R

Citation: D. Jonkers et al., Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative, ITAL J GAST, 31(9), 1999, pp. 836-841

Authors: Sanduleanu, S Stridsberg, M Jonkers, D Hameeteman, W Biemond, I Lundqvist, G Lamers, C Stockbrugger, RW

Citation: S. Sanduleanu et al., Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study, ALIM PHARM, 13(2), 1999, pp. 145-153